SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pojak watched as the world played hot potato with CTO shit coins. Now, it's his moment. With Pepe's legendary meme power and Wojak's emotional depth, Pojak brings a new level of influence, wealth, and ethics. Born into meme royalty with luxury and wisdom from Pepe and Wojak, he faced hardship when the original developer rugged the project. The community rose up and took control. Pojak was reborn, stronger and more determined.

Pojak

PJ CRYPTO ($PJ) is trending as it gains traction within the Phantom Wallet community. The community highlights its strong chart and growing momentum, viewing it as an opportunity for early movers. Some caution is being advised as well.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets (SSB) is trending as community members discuss new coins launching on Phantom Wallet and those building momentum. Several coins, including $1DOG, $CHINAWINS, and $KABOOM, are generating significant buzz within the SSB community. Discussions also highlight projects focusing on community building and locked liquidity, reflecting a growing interest in projects prioritizing trust and transparency.

Lynas Rare Earths Ltd. engages in the production of rare earth minerals. It focuses on the exploration, development, mining, and processing of rare earth deposits. The company was founded by Nicholas Anthony Curtis on May 23, 1983 and is headquartered in Perth, Australia.

Lynas Rare Earths Limited

Lynas Rare Earths is trending due to potential US and Australian rare earth deals, with community members speculating on upcoming meetings and long-term supply agreements. Some investors are discussing the recent price drop as a profit-taking opportunity, while others highlight the company's strong fundamentals and increasing demand for rare earth materials. The community also discusses potential partnerships and expansions, especially the U.S. plant.

Aptera Motors Corp. is an automotive technology company focused on the development, production, and distribution of energy-efficient, solar-powered, battery-electric vehicles. Its flagship product, the Aptera, is a three-wheeled, two-seat solar vehicle designed to reduce reliance on traditional charging by utilizing integrated solar panels. The company was founded by Steve Fambro and Chris Anthony and is headquartered in San Diego, CA.

Aptera Motors Corp - Ordinary Shares - Class B

Aptera Motors Corp

Aptera Motors ($SEV) is trending due to its recent direct listing, which has been marked by extreme volatility and trading halts, sparking community debate about market manipulation. Discussions revolve around the company's long-term viability, production capabilities, and unique solar-powered vehicle design, with some comparing it to other EV companies. The community is actively questioning the stock's potential and speculating on future price movements.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is trending as investors discuss its future growth potential amid mixed sentiments around revenue guidance and a discount program impacting profitability. The community is actively analyzing the implications of the CHOPIN trial data expected at #esmo2025, which could significantly expand the use of their Hepzato Kit, and whether it might attract buyout interest. Discussions also involve revenue expectations, potential cash flow, and the impact of expanded clinical trials on the company's financial strategy.

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.

Tempest Therapeutics Inc

TPST is trending amid community speculation about a potential acquisition, fueled by upcoming industry events and chatter around Roche. Discussions revolve around buyout values, potential buyers, and the timing of a deal announcement, with many citing the approaching expiration of management options as a key deadline. The community is weighing the likelihood of a buyout against the backdrop of the company's financial situation and the broader oncology market.

Quantum Resistant Ledger is a cryptocurrency based on the Python programming language, aimed at combating future attacks by quantum computers. This cryptocurrency is the brainchild of Peter Waterland who realised that Bitcoin, Ethereum, and other such cryptocurrencies have no protection against future technology. It claims to be a “future-proof” cryptocurrency which enables transactions and decentralized communication while providing protection against classical as well as quantum computer attacks.  The Quantum Resistant Ledger company was founded by Peter Waterland, who found that Bitcoin, as well as Ethereum signatures are susceptible to attacks by powerful quantum computers. His research on quantum computers and signature programs let to the development of this new cryptocurrency, designed to be resistant to the present classical attacks as well as any future quantum computer attacks. Their team is made up of a diverse range of members spread out across the world, including developers (core, blockchain, mobile developers, etc.), analysts, advisors, marketing managers, designers and more.  Quantum Resistant Ledger is the first ever cryptocurrency and the only one in existence as of August 2018, to consider the threat that the future technology of quantum computing poses to cryptocurrencies and their working. It uses a technology specifically designed for post-quantum security, called XMSS, which makes it secure against powerful quantum computers even while using a Proof-of-Stake consensus mechanism. Security against cyber-attacks is a very serious concern in this digital age, especially when you have digital assets whose loss is likely to lead you to bankruptcy.  QRL is the first blockchain technology that provides durability and stability through resistance to quantum computer attacks. The encryption methods used by modern blockchains can become vulnerable to quantum computers over the next ten years. QRL tries to create a blockchain with long-term stability. By using blockchain technology, the QRL platform creates a “ledger” that generates hashes in such a way that it is virtually impenetrable to any type of computer attack.

Quantum Resistant Ledger 

Quantum Resistant Ledger is trending as discussions around quantum computing's potential impact on blockchain security intensify, particularly its threat to current encryption methods used by Bitcoin and other major cryptocurrencies. The community highlights QRL's quantum-resistant design from its inception in 2018, suggesting it as a hedge against future quantum attacks and anticipating potential listings on major exchanges. Recent news of advancements in quantum computing and government initiatives for quantum-resistant standards are fueling the conversation around QRL as a proactive solution.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa ($V) is trending amid discussions around its strategic moves in stablecoins, AI-driven security, and partnerships, with some analysts anticipating a potential breakout. Community members are weighing the stock's potential against that of competitors and assessing its value in light of consumer spending trends. Several sources point to a potential earnings beat, although some express concern about the stock's recent performance.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound ($COMP) is trending as traders debate its next move, with some anticipating a breakout while others foresee a price dump. Community discussions revolve around potential short squeezes and the impact of dilution on the token's value. Amidst the volatility, some investors express optimism, citing the low supply and potential for a significant upward swing.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors discuss its potential for acquisition following strategic moves like the Recordati partnership and new data presentations at the European Society of Cardiology (ESC) Congress. The community highlights the company's restructured financials, a strong patent portfolio, and identified synergies, interpreting these factors as signs of increased attractiveness to potential acquirers. Discussions also involve potential combination therapies and ongoing patent litigation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Do Options Traders Know Something About Repligen Stock We Don't?

Investors need to pay close attention to RGEN stock based on the movements in the options market lately.

Repligen (RGEN) Lags Q2 Earnings Estimates

Repligen (RGEN) delivered earnings and revenue surprises of -7.50% and +3.56%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Repligen (RGEN) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Do Options Traders Know Something About Repligen (RGEN) Stock We Don't?

Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report?

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors BioLife Solutions Appoints Tony J. Hunt to its Board of Directors PR Newswire BOTHELL, Wash., Dec. 16, 2024 BOTHELL, Wash., Dec. 16...

Repligen Q3 Earnings Beat Expectations, Highlights Improving Market Conditions, Analyst Says Well-Positioned For Long-Term Growth

Repligen Q3 earnings beat expectations with $0.43 EPS and $154.87 million in sales. The company raises 2024 EPS guidance and reports strong growth in CDMO and equipment.

 Latest Ratings for RGEN...

Buy Rating Affirmed: Overlooked Long-Term Benefits of Repligen's Potential Maravai Acquisition

Analyst Justin Bowers from Deutsche Bank maintained a Buy rating on Repligen (RGEN Research Report) and increased the price target to $175.00 fro...

Repligen Lowers Guidance On China Weakness, Analyst Expects

Repligen reports Q2 sales of $154.1 million, closely matching the consensus estimate. Adjusted gross margin fell to 49.6% from 50.2%, with an EPS of $0.33. CEO Tony J. Hunt highlights strong Pharma...

Ecolab Life Sciences and Repligen Announce the Commercial Launch of DurA Cycle Affinity Resin for Large-Scale Biologic Manufacturing

Ecolab today announced that its Purolite resin business, together with Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the...

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Repligen Corp.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$152.60
Prev Close	$154.55
Open	$153.50
Dividend Yield	0.00%
50-Day Moving Average	$128.59
Beta	1.52
Avg. Volume	821,989.62
PE Ratio	-611.13

52-Week High	$182.52
52-Week Low	$102.97
Market Capitalization	$8.58B
EPS (Annual)	-$0.4561
Price to Book	4.16
Revenue Per Employee	$356,827.33
Enterprise Value/EBITDA	N/A

RGEN
Repligen Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RGEN News

RGENRepligen Corp.